ArticleCancer medicine2021

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Hisao Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.